Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

29 trials with published results (25%)

Research Maturity

66 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

7.0%

8 terminated out of 115 trials

Success Rate

89.2%

+2.7% vs benchmark

Late-Stage Pipeline

22%

25 trials in Phase 3/4

Results Transparency

44%

29 of 66 completed with results

Key Signals

29 with results89% success

Data Visualizations

Phase Distribution

90Total
Not Applicable (33)
P 1 (13)
P 2 (19)
P 3 (20)
P 4 (5)

Trial Status

Completed66
Unknown19
Recruiting13
Terminated8
Active Not Recruiting7
Not Yet Recruiting2

Trial Success Rate

89.2%

Benchmark: 86.5%

Based on 66 completed trials

Clinical Trials (115)

Showing 20 of 20 trials
NCT07081997Phase 3Recruiting

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

NCT06226545Phase 2Completed

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

NCT06619834Not ApplicableCompleted

Financial Navigation and Peer Support to Improve Diabetes Outcomes

NCT07413874Not ApplicableNot Yet Recruiting

Telehealth Music Therapy for Adults With Endocrine Disorder and Depression

NCT04701203Phase 3Completed

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism

NCT05387070Phase 3Completed

PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism

NCT07348432Recruiting

The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes

NCT05171855Phase 3Completed

A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency

NCT05014204Not ApplicableCompleted

Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes

NCT07196917Not Yet Recruiting

Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China

NCT05778071Phase 3Active Not Recruiting

Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism

NCT05260021Phase 3Completed

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

NCT05910840Not ApplicableRecruiting

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care

NCT06069583Not ApplicableRecruiting

Implementation of Support in the Care of Adults Living With Type 1 Diabetes

NCT05749770Completed

Hormonal Contributors to COVID-19 Infection (COV-ENDO)

NCT05544266Recruiting

Rare and Atypical Diabetes Network

NCT04700436Phase 4CompletedPrimary

Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia

NCT05022667Not ApplicableCompleted

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

NCT05691712Phase 3Completed

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes

NCT04972955Active Not Recruiting

Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose Monitoring

Scroll to load more

Research Network

Activity Timeline